Long-term Response of <i>Helicobacter pylori</i> Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study-Reference-Cited by-同舟云学术

Long-term Response of Helicobacter pylori Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study

Published:2021 Issue: Volume: Page:
ISSN:0917-5040
Container-title:Journal of Epidemiology
language:en
Short-container-title:Journal of Epidemiology

Author:

Tanaka Shiori¹^ORCID,Goto Atsushi¹,Yamagishi Kazumasa²^ORCID,Iwasaki Motoki¹,Yamaji Taiki¹,Shimazu Taichi¹^ORCID,Iso Hiroyasu²^ORCID,Muraki Isao³^ORCID,Yasuda Nobufumi⁴^ORCID,Saito Isao⁵^ORCID,Kato Tadahiro⁶,Aoyagi Kiyoshi⁷,Arima Kazuhiko⁷^ORCID,Sakata Kiyomi⁸,Tanno Kozo⁸^ORCID,Inoue Manami¹^ORCID,Sawada Norie¹^ORCID,Tsugane Shoichiro¹^ORCID

Affiliation:

1. Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center

2. Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba

3. Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine

4. Department of Public Health, Kochi University Medical School

5. Department of Public Health and Epidemiology, Faculty of Medicine, Oita University

6. Center for Education and Educational Research, Faculty of Education, Ehime University

7. Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences

8. Department of Hygiene and Preventive Medicine, Iwate Medical University

Publisher

Japan Epidemiological Association

Subject

General Medicine,Epidemiology

Link

https://www.jstage.jst.go.jp/article/jea/advpub/0/advpub_JE20200618/_pdf

Reference54 articles.

1. 1. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–490.

2. 2. IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. Lyon, France: International Agency for Research on Cancer (IARC); December 2013 2014.

3. 5. Matsuda T, Saika K. Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs. Ann Cancer Epidemiol. 2018;2.

4. 8. Li WQ, Ma JL, Zhang L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014;106(7):dju116.

5. 10. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;348:g3174.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection;American Journal of Gastroenterology;2024-09

2. Analyses of the association betweenHelicobacter pyloriantibody titre and pathogenicity before and after eradication: results of the Kyushu and Okinawa population study, a retrospective observational cohort study;BMJ Open;2024-08

3. Feco-prevalence, endoscopic pattern and associated factors of Helicobacter Pylori infection among symptomatic adult patients in Northern Tanzania;PLOS ONE;2024-07-22

4. Clinical Characteristics of Patients With Previous Helicobacter pylori Infection-Induced Atrophic Gastritis;Cureus;2024-06-28

5. Response to Yu and Fuhleret al;Journal for ImmunoTherapy of Cancer;2024-01